1 month ago
6
(NewsNation) — Drugmakers Eli Lilly and Novo Nordisk are reportedly moving retired a woody with the Trump medication to chopped the prices of their value nonaccomplishment drugs.
According to Reuters, Lilly could connection the lowest dose of its fashionable value nonaccomplishment cause Zepbound astatine $149 a month, and Novo's Wegovy could beryllium offered astatine $299 a period done TrumpRx. In return, the 2 drugs could besides summation sum nether Medicare.
Eli Lilly is besides negotiating for a authorities voucher that would expedite national reappraisal of a value nonaccomplishment pill it's looking to bring to the market, according to the Wall Street Journal.
President Donald Trump has accrued unit connected cause companies to little their medicine costs successful caller months.
In May, helium signed an executive order to instrumentality a "most-favored nation" policy, which would headdress costs based connected different countries’ medicine prices, a determination Trump said could driblet prices for Americans by 30% to 80%.
Since that enforcement bid was signed, Trump has reached deals with drugmakers Pfizer and AstraZeneca to little cause costs.
Spokespersons for some Eli Lilly and Novo Nordisk told the Wall Street Journal they are successful negotiations with the medication and are looking to "promote affordability" of their medications.
